Global Leukemia Academy
Webinar on Recent Updates in Pediatric and AYA ALL
Overview
Aptitude Health organized a webinar on recent updates in pediatric and AYA ALL, which included information from major conferences, as well as recent publications.
Experts shared their insights on enactment of new paradigms, including administration of new treatments such as bispecifics and patient monitoring and management. They also discussed strategic implementation of minimal residual disease (MRD) monitoring.
Date and Location
4 September 2020
3.00 pm – 4.00 pm EDT (Eastern Daylight Time)/
4.00 pm – 5.00 pm BRT (Brasilia Time)/
21.00 – 22.00 CET (Central European Time)
Virtual Meeting
Meeting Content
View the slides and watch the video of the webinar
on Recent Updates in Pediatric and AYA ALL
Ask your questions directly to the experts and receive their personal insights on current and novel treatment approaches for pediatric and adult patients with acute leukemias.
Faculty
Patrick A. Brown, MD
Johns Hopkins University
School of Medicine, USA
Rupert Handgretinger, MD, PhD
Children’s University Hospital and
Department of Hematology/Oncology,
Germany
Franco Locatelli, MD, PhD
University of Rome
IRCCS Ospedale Pediatrico
Bambino Gesù, Italy
|
Agenda |
This meeting was a 1-hour virtual event. |
| Time, EDT | Topic | Presenter | |
| 3.00 PM – 3.05 PM/ (5 min) |
Welcome and Introductions | Rupert Handgretinger, MD | |
| 3.05 PM – 3.15 PM/ (10 min) |
Current Paradigm and Long-term Toxicities for Pediatric ALL • Integration of innovative immunotherapies • Role of MRD in treatment • Long-term toxicities |
Franco Locatelli, MD, PhD | |
| 3.15 PM – 3.30 PM/ (15 min) |
Bispecifics for Pediatric/AYA ALL • Review of trial results in pediatric/AYA ALL • Role of MRD in research and treatment • AYA considerations |
Patrick Brown, MD | |
| 3.30 PM – 3.40 PM/ (10 min) |
CAR T-cells for Pediatric/AYA ALL • Benefits and risks of CAR Ts and bispecifics • Role of MRD in research and treatment • AYA considerations |
Franco Locatelli, MD, PhD | |
| 3.40 PM – 4.00 PM/ (20 min) |
Questions to Experts | Rupert Handgretinger, MD |
